Table: Astellas -2024/25 group forecast(IFRS)

Astellas Pharma

24/01/2025 07:00

Jan 24 (Reuters) -
              Astellas Pharma Inc.     
              CONSOLIDATED EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2025      Mar 31, 2025   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales          1.90 trln         1.80 trln    
  Operating        11.00             80.00      
  PreTax            1.00             70.00      
  Net              14.00             50.00      
  EPS Basic      7.82 yen          27.93 yen    
 
  NOTE - Astellas Pharma Inc..(Figures are reported based on international accounting rules (IFRS).)    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4503.T